| Next-generation characterization of the cancer cell line encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503-508, 2019 | 2752 | 2019 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1971* | 2020 |
| Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition AN Hata, MJ Niederst, HL Archibald, M Gomez-Caraballo, FM Siddiqui, ... Nature medicine 22 (3), 262-269, 2016 | 989 | 2016 |
| Genetic and transcriptional evolution alters cancer cell line drug response U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ... Nature 560 (7718), 325-330, 2018 | 880 | 2018 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 571 | 2020 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 547 | 2020 |
| Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease K Ohashi, YE Maruvka, F Michor, W Pao Journal of Clinical Oncology, 2013 | 537 | 2013 |
| A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer P Polak, J Kim, LZ Braunstein, R Karlic, NJ Haradhavala, G Tiao, ... Nature genetics 49 (10), 1476-1486, 2017 | 535 | 2017 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 522 | 2019 |
| Polyploidy can drive rapid adaptation in yeast AM Selmecki, YE Maruvka, PA Richmond, M Guillet, N Shoresh, ... Nature 519 (7543), 349-352, 2015 | 484 | 2015 |
| Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair NJ Haradhvala, P Polak, P Stojanov, KR Covington, E Shinbrot, JM Hess, ... Cell 164 (3), 538-549, 2016 | 442 | 2016 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 380 | 2020 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 371 | 2020 |
| Recurrent and functional regulatory mutations in breast cancer E Rheinbay, P Parasuraman, J Grimsby, G Tiao, JM Engreitz, J Kim, ... Nature 547 (7661), 55-60, 2017 | 334 | 2017 |
| WRN helicase is a synthetic lethal target in microsatellite unstable cancers EM Chan, T Shibue, JM McFarland, B Gaeta, M Ghandi, N Dumont, ... Nature 568 (7753), 551-556, 2019 | 325 | 2019 |
| Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ... Nature cancer 1 (5), 493-506, 2020 | 296 | 2020 |
| Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair NJ Haradhvala, J Kim, YE Maruvka, P Polak, D Rosebrock, D Livitz, ... Nature communications 9 (1), 1746, 2018 | 186 | 2018 |
| Analysis of somatic microsatellite indels identifies driver events in human tumors YE Maruvka, KW Mouw, R Karlic, P Parasuraman, A Kamburov, P Polak, ... Nature biotechnology 35 (10), 951-959, 2017 | 138 | 2017 |
| Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident LM Morton, DM Karyadi, C Stewart, TI Bogdanova, ET Dawson, ... Science 372 (6543), eabg2538, 2021 | 129 | 2021 |
| The genomic and immune landscapes of lethal metastatic breast cancer L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ... Cell reports 27 (9), 2690-2708. e10, 2019 | 118 | 2019 |
Gad GetzMassachusetts General Hospital and Broad Institute of Harvard and MITVerified email at broadinstitute.org
